KLF5, a Novel Therapeutic Target in Squamous Cell Carcinoma

Squamous cell carcinomas (SCCs) are the most common ectodermal cancers, and result in more than 300,000 deaths per year. The Kruppel-like family of transcription factors play a critical role in cancer pathogenesis. The Kruppel-like factor 5 gene (KLF5), which is a member of Kruppel-like family, has been reported to promote cancer cell proliferation and tumorigenesis. In this review, we discuss the roles of KLF5 in different SCCs and the mechanisms by which KLF5 transcriptionally regulates its target gene expression in the pathogenesis and progression of SCCs. Due to its significant functions in cell proliferation and differentiation, KLF5 could be a novel diagnostic biomarker and therapeutic target for the treatment of SCCs.

Automated summary

KLF5 plays a critical role in squamous cell carcinomas and could be a novel diagnostic biomarker and therapeutic target for treatment.